发明名称 |
Diagnosis and treatment of Alzheimer's disease |
摘要 |
Methods are provided for the prevention, treatment and diagnosis of Alzheimer's disease, based on the glycosylation pattern of amyloid-beta peptides in body fluids and tissues. |
申请公布号 |
US8916387(B2) |
申请公布日期 |
2014.12.23 |
申请号 |
US201113881387 |
申请日期 |
2011.10.28 |
申请人 |
|
发明人 |
Nilsson Jonas;Halim Adnan;Larson Göran;Blennow Kaj;Brinkmalm Gunnar;Portelius Erik;Zetterberg Henrik |
分类号 |
G01N24/00;G01N24/14;G01N33/68;H01J49/00;A61K39/00 |
主分类号 |
G01N24/00 |
代理机构 |
|
代理人 |
Barber Lynn E. |
主权项 |
1. An in vitro method for diagnosing or prognosing Alzheimer's disease in a subject, or determining whether a subject is at increased risk of developing Alzheimer's disease, comprising the steps of:
a) obtaining a sample from the subject; b) enriching for Abeta peptides in the sample; c) separating the Abeta peptides of step b) using liquid chromatography; d) identifying Abeta peptide fragments by mass spectrometry; e) measuring the level of O-linked glycosylation at Tyr10 of the Abeta peptides; and f) utilizing information on the level of O-linked glycosylation at Tyr10 of the Abeta peptides in the sample as compared to a reference value representing a known disease or health status to diagnose or prognose Alzheimer's disease in the subject, or to determine whether there is an increased risk of Alzheimer's disease in the subject. |
地址 |
|